Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

SN1 Reaction: Stereochemistry02:15

SN1 Reaction: Stereochemistry

10.4K
This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
10.4K
SN1 Reaction: Kinetics02:05

SN1 Reaction: Kinetics

9.6K
In an SN2 reaction, the reaction rate depends on both the type of nucleophile and the substrate. A hindered tertiary alkyl halide is practically inert to the SN2 mechanism despite using a strong nucleophile.
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
9.6K
SN1 Reaction: Mechanism02:25

SN1 Reaction: Mechanism

14.4K
Kinetic studies of ionization of a tertiary halide in a protic solvent suggest that only the substrate participates in the rate-determining step (slow step). The nucleophile is involved only after the slowest step. The SN1 reaction takes place in a multiple-step mechanism. 
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
14.4K
Acidity of 1-Alkynes02:42

Acidity of 1-Alkynes

11.2K

The acidic strength of hydrocarbons follows the order: Alkynes > Alkenes > Alkanes. The strength of an acid is commonly expressed in units of pKa — the lower the pKa, the stronger the acid. Among the hydrocarbons, terminal alkynes have lower pKa values and are, therefore, more acidic. For example, the pKa values for ethane, ethene, and acetylene are 51, 44, and 25, respectively, as shown here.
11.2K
Predicting Products: SN1 vs. SN202:27

Predicting Products: SN1 vs. SN2

17.4K
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
17.4K
Patient-centered Care01:13

Patient-centered Care

3.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The current state of palliative care research in heart failure.

ESC heart failure·2026
Same author

SARS-CoV-2-infected cardiomyocytes exhibit upregulated necroptosis, but no evidence of mitochondrial permeability transition.

Journal of molecular and cellular cardiology plus·2026
Same author

PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Characterization of ferric hydroxysulfate on Mars and implications of the geochemical environment supporting its formation.

Nature communications·2025
Same author

Comparative analysis of cell morphology in patient-paired primary human osteoblasts from the jaw and the fibula.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery·2024
Same author

Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study.

Endocrine-related cancer·2024
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

Related Experiment Video

Updated: Feb 6, 2026

Combining Augmented Reality and 3D Printing to Display Patient Models on a Smartphone
09:26

Combining Augmented Reality and 3D Printing to Display Patient Models on a Smartphone

Published on: January 2, 2020

19.0K

[Longterm Homecare Augmentation Program in Alpha-1-Antitrypsin Deficient Patients].

A Wilke1, H Semper1, C Gross1

  • 1Klinik für Pneumologie, Ev. Lungenklinik Berlin.

Pneumologie (Stuttgart, Germany)
|August 9, 2018
PubMed
Summary
This summary is machine-generated.

Home care augmentation therapy for Alpha-1-Antitrypsin Deficiency (AATD) slowed disease progression and improved quality of life. The "Alpha-1-Mobile" program was safe, practical, and well-accepted by patients.

More Related Videos

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.7K
Pedicle Screw Placement Using an Augmented Reality Head-Mounted Display in a Porcine Model
06:18

Pedicle Screw Placement Using an Augmented Reality Head-Mounted Display in a Porcine Model

Published on: May 24, 2024

2.7K

Related Experiment Videos

Last Updated: Feb 6, 2026

Combining Augmented Reality and 3D Printing to Display Patient Models on a Smartphone
09:26

Combining Augmented Reality and 3D Printing to Display Patient Models on a Smartphone

Published on: January 2, 2020

19.0K
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.7K
Pedicle Screw Placement Using an Augmented Reality Head-Mounted Display in a Porcine Model
06:18

Pedicle Screw Placement Using an Augmented Reality Head-Mounted Display in a Porcine Model

Published on: May 24, 2024

2.7K

Area of Science:

  • Pulmonary Medicine
  • Genetic Disorders
  • Pharmacotherapy

Background:

  • Alpha-1-Antitrypsin Deficiency (AATD) is a rare genetic condition leading to progressive COPD.
  • Augmentation therapy with human alpha-1 proteinase inhibitor is the sole specific treatment for AATD.

Purpose of the Study:

  • To prospectively evaluate the long-term outcomes of the "Alpha-1-Mobile" home care augmentation program.
  • To assess the impact of home-based augmentation therapy on advanced-stage AATD patients.

Main Methods:

  • Seven advanced-stage AATD patients received weekly intravenous AAT augmentation and COPD management at home.
  • Continuous monitoring of symptoms, lung function (FEV1), health status, quality of life, and safety over six years.
  • Comparison of FEV1 decline rates before and during the home care program.

Main Results:

  • The decline in FEV1 significantly slowed during home care compared to the pre-program period (0.17 L/year vs. 0.47 L/year).
  • Quality of life scores stabilized after an initial period of fluctuation.
  • Therapeutic AAT levels ( >50 mg/dL) were maintained with a 60 mg/kg/week dose, with no observed adverse events.

Conclusions:

  • Home care AAT augmentation by medical professionals ensures consistent treatment and close monitoring for AATD patients.
  • The "Alpha-1-Mobile" program effectively reduced exacerbation-related hospitalizations.
  • The program demonstrated safety, practicality, and high patient acceptance.